Cargando…
Biological Pathways and Potential Targets for Prevention and Therapy of Chronic Allograft Nephropathy
Renal transplantation (RT) is the best option for patients with end-stage renal disease, but the half-life is limited to a decade due to progressive deterioration of renal function and transplant failure from chronic allograft nephropathy (CAN), which is the leading cause of transplant loss. Extensi...
Autores principales: | Shrestha, Badri Man, Haylor, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058292/ https://www.ncbi.nlm.nih.gov/pubmed/24971332 http://dx.doi.org/10.1155/2014/482438 |
Ejemplares similares
-
Experimental rat models of chronic allograft nephropathy: a review
por: Shrestha, Badri, et al.
Publicado: (2014) -
Upregulation of Transglutaminase and ε
(γ-Glutamyl)-Lysine in the Fisher-Lewis Rat Model of
Chronic Allograft Nephropathy
por: Shrestha, Badri, et al.
Publicado: (2014) -
Chronic allograft nephropathy
por: Fletcher, Jeffery T., et al.
Publicado: (2009) -
A reproducible mouse model of chronic allograft nephropathy with vasculopathy
por: Zarjou, Abolfazl, et al.
Publicado: (2012) -
Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets
por: Liu, Bin, et al.
Publicado: (2013)